AbCellera Biologics Inc.
|
-0.51 USD
|
672.549%
|
Alkermes plc
|
2.14 USD
|
-36.449%
|
Agenus Inc.
|
-13.75 USD
|
121.236%
|
Aptorum Group Limited
|
-0.62 USD
|
570.968%
|
Ardelyx, Inc.
|
-0.30 USD
|
1073.333%
|
Dyadic International, Inc.
|
-0.24 USD
|
1316.667%
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
8100.0%
|
Lantern Pharma Inc.
|
-1.47 USD
|
298.639%
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
181.793%
|
Novavax, Inc.
|
-5.41 USD
|
153.974%
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
321.212%
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
257.838%
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
102.818%
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
734.783%
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
161.864%
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
114.607%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
333.6%
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
317.91%
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
150.258%
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
252.88%
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
103.166%
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
748.889%
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
650.943%
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
209.363%
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
182.955%
|
AlloVir, Inc.
|
-1.83 USD
|
259.563%
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
252.88%
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
205.415%
|
Bicycle Therapeutics plc
|
-5.08 USD
|
157.48%
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
147.48%
|
ChromaDex Corporation
|
-0.07 USD
|
4530.956%
|
Chimerix, Inc.
|
-0.93 USD
|
413.978%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
128.322%
|
Caribou Biosciences, Inc.
|
-1.38 USD
|
311.594%
|
CRISPR Therapeutics AG
|
-1.94 USD
|
250.515%
|
Precision BioSciences, Inc.
|
-15.96 USD
|
118.296%
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
278.049%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
134.475%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
134.475%
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
133.835%
|
ImmuCell Corporation
|
-0.75 USD
|
489.333%
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
248.98%
|
Immix Biopharma, Inc.
|
-0.89 USD
|
428.09%
|
Incyte Corporation
|
2.67 USD
|
-9.363%
|
IO Biotech, Inc.
|
-1.98 USD
|
247.475%
|
Jaguar Health, Inc.
|
-107.42 USD
|
102.718%
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
156.154%
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
3.311%
|
ContextLogic Inc.
|
-13.36 USD
|
121.856%
|
MiMedx Group, Inc.
|
0.48 USD
|
-508.333%
|
MEI Pharma, Inc.
|
2.67 USD
|
-9.363%
|
NextCure, Inc.
|
-2.25 USD
|
229.778%
|
Onconetix, Inc.
|
-2.19 USD
|
233.333%
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
121.742%
|
Opthea Limited
|
-0.35 USD
|
934.286%
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
137.197%
|
Vaxcyte, Inc.
|
-4.14 USD
|
170.531%
|
PDS Biotechnology Corporation
|
-1.39 USD
|
310.072%
|
Precigen, Inc.
|
-0.39 USD
|
848.718%
|
Pharming Group N.V.
|
-0.16 USD
|
1925.0%
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
174.3%
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
113.394%
|
PureTech Health plc
|
-2.38 USD
|
222.689%
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
302.778%
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
200.344%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
333.6%
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
297.297%
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
389.109%
|
Acelyrin, Inc.
|
-5.43 USD
|
153.775%
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
76942.105%
|
Summit Therapeutics Inc.
|
-0.99 USD
|
394.949%
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
339.344%
|
Senti Biosciences, Inc.
|
-16.01 USD
|
118.239%
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
222.689%
|
Elevation Oncology, Inc.
|
-1.34 USD
|
317.91%
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
113.291%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
763.636%
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
1560.0%
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
292.105%
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
190.402%
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
640.741%
|
Seer, Inc.
|
-1.35 USD
|
316.296%
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
297.297%
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
219.672%
|
ESSA Pharma Inc.
|
-0.60 USD
|
586.667%
|
GlycoMimetics, Inc.
|
-0.58 USD
|
603.448%
|
GT Biopharma, Inc.
|
-5.64 USD
|
151.773%
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
157.031%
|
Akebia Therapeutics, Inc.
|
-0.28 USD
|
1142.857%
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
-335.821%
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
222.176%
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
297.297%
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
119.837%
|
Sorrento Therapeutics, Inc.
|
-1.37 USD
|
313.139%
|
TRACON Pharmaceuticals, Inc.
|
-2.20 USD
|
232.727%
|
Viracta Therapeutics, Inc.
|
-1.32 USD
|
321.212%
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
200.0%
|
Aptose Biosciences Inc.
|
-7.58 USD
|
138.522%
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
100.268%
|
Soligenix, Inc.
|
-12.66 USD
|
123.065%
|
Century Therapeutics, Inc.
|
-2.30 USD
|
226.957%
|
Kura Oncology, Inc.
|
-2.08 USD
|
240.385%
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
314.706%
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
311.594%
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
11202.662%
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
38022.078%
|
Autolus Therapeutics plc
|
-1.20 USD
|
343.333%
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
246.734%
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
260.44%
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
171.569%
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
287.179%
|
GRI Bio, Inc.
|
-28.25 USD
|
110.336%
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
207.749%
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
273.81%
|
IGM Biosciences, Inc.
|
-4.71 USD
|
161.996%
|
INmune Bio, Inc.
|
-1.67 USD
|
274.85%
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
465.0%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
138.22%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
123.083%
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
106.099%
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
310.072%
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
612.281%
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
104.48%
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
215.415%
|
Verastem, Inc.
|
-3.96 USD
|
173.737%
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
215.415%
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
206.182%
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
101.333%
|
Histogen Inc.
|
-3.46 USD
|
184.393%
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
173.924%
|
Surrozen, Inc.
|
-21.33 USD
|
113.69%
|
Organovo Holdings, Inc.
|
-1.60 USD
|
282.5%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
209.774%
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
494.595%
|
Panbela Therapeutics, Inc.
|
-232.42 Thousand USD
|
100.001%
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
244.554%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
570.968%
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
285.987%
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
123.701%
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
360.714%
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
218.219%
|
Apollomics, Inc.
|
-2.32 USD
|
225.862%
|
Amarin Corporation plc
|
-0.15 USD
|
2046.667%
|
Mesoblast Limited
|
-0.89 USD
|
428.09%
|
Turnstone Biologics Corp.
|
-4.77 USD
|
161.216%
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
215.873%
|
Synaptogenix, Inc.
|
-29.56 USD
|
109.878%
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
1925.0%
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
640.741%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
1106.897%
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
603.448%
|
Exelixis, Inc.
|
0.65 USD
|
-349.231%
|
Better Therapeutics, Inc.
|
-1.69 USD
|
272.781%
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
210.189%
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
165.618%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
1012.5%
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
107.267%
|
Aridis Pharmaceuticals, Inc.
|
-1.64 USD
|
278.049%
|
Gritstone bio, Inc.
|
-1.20 USD
|
343.333%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
147.249%
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
154.784%
|
Avid Bioservices, Inc.
|
-2.23 USD
|
230.942%
|
Insmed Incorporated
|
-5.34 USD
|
154.682%
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
122.513%
|
MediWound Ltd.
|
-0.75 USD
|
489.333%
|
OmniAb, Inc.
|
-0.51 USD
|
672.549%
|
Alector, Inc.
|
-1.56 USD
|
287.179%
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
428.09%
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
205.415%
|
Zai Lab Limited
|
-3.46 USD
|
184.393%
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
176.24%
|
Aura Biosciences, Inc.
|
-1.93 USD
|
251.295%
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
413.978%
|
Immunic, Inc.
|
-2.11 USD
|
238.389%
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
163.203%
|
Veracyte, Inc.
|
-1.02 USD
|
386.275%
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
389.109%
|
FibroGen, Inc.
|
-2.92 USD
|
200.0%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
109.64%
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
153.676%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
116.097%
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
57.986%
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
110.916%
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
-300.0%
|
TG Therapeutics, Inc.
|
0.09 USD
|
-3169.877%
|
Galecto, Inc.
|
-36.08 USD
|
108.093%
|
Calithera Biosciences, Inc.
|
-7.94 USD
|
136.776%
|
Fortrea Holdings Inc.
|
-0.04 USD
|
7724.021%
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
184.884%
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
104.663%
|
XBiotech Inc.
|
-0.81 USD
|
460.494%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
147.249%
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
331.746%
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
224.786%
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
695.918%
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
392.0%
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
135.394%
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
260.44%
|
Vaxxinity, Inc.
|
-0.45 USD
|
748.889%
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
347.458%
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
270.76%
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
106.872%
|
NexImmune, Inc.
|
-30.82 USD
|
109.474%
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
177.66%
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
251.295%
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
92.119%
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
241.748%
|
Scopus BioPharma Inc.
|
-0.55 USD
|
630.909%
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
195.738%
|
Ainos, Inc.
|
-3.36 USD
|
186.905%
|
Pluri Inc.
|
-3.99 USD
|
173.183%
|
Prothena Corporation plc
|
-2.76 USD
|
205.797%
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
612.281%
|
Celularity Inc.
|
-11.02 USD
|
126.497%
|
Rallybio Corporation
|
-1.84 USD
|
258.696%
|
Cue Biopharma, Inc.
|
-1.11 USD
|
363.063%
|
MeiraGTx Holdings plc
|
-1.49 USD
|
295.973%
|
Omeros Corporation
|
-1.88 USD
|
255.319%
|
Humacyte, Inc.
|
-1.07 USD
|
372.897%
|
Immunocore Holdings plc
|
-1.13 USD
|
358.407%
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
256.989%
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
155.619%
|
Blueprint Medicines Corporation
|
-8.37 USD
|
134.886%
|
CalciMedica, Inc.
|
-7.65 USD
|
138.17%
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
276.97%
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
211.027%
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
246.734%
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
300.0%
|
Pulmatrix, Inc.
|
-3.87 USD
|
175.452%
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
141.954%
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
237.089%
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
153.875%
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
140.22%
|
Cytokinetics, Incorporated
|
-5.45 USD
|
153.578%
|
Eloxx Pharmaceuticals, Inc.
|
-16.65 USD
|
117.538%
|
Nutriband Inc.
|
-0.69 USD
|
523.188%
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
181.793%
|
Vor Biopharma Inc.
|
-1.75 USD
|
266.857%
|
Roivant Sciences Ltd.
|
5.55 USD
|
47.387%
|
Evogene Ltd.
|
-5.23 USD
|
155.832%
|
ProKidney Corp.
|
-0.57 USD
|
612.281%
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
305.634%
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
226.957%
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
173.924%
|
CorMedix Inc.
|
-0.91 USD
|
420.879%
|
BioLineRx Ltd.
|
-0.94 USD
|
410.638%
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
370.37%
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
494.595%
|
Atai Life Sciences N.V.
|
-0.25 USD
|
1268.0%
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
447.619%
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
201.742%
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
165.324%
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
209.774%
|
MediciNova, Inc.
|
-0.17 USD
|
1817.647%
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
115.623%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
542.424%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
128.571%
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
155.408%
|
Biomea Fusion, Inc.
|
-3.44 USD
|
184.884%
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
134.886%
|
Mereo BioPharma Group plc
|
-0.04 USD
|
6632.438%
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
179.133%
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
197.987%
|
Absci Corporation
|
-1.20 USD
|
343.333%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
173.367%
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
213.178%
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
173.924%
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
-1360.0%
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
188.485%
|
Allakos Inc.
|
-2.14 USD
|
236.449%
|
Imunon, Inc.
|
-2.16 USD
|
235.185%
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
283.648%
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
-186.275%
|
BioAtla, Inc.
|
-2.58 USD
|
213.178%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
1012.5%
|
Bio-Path Holdings, Inc.
|
-33.64 USD
|
108.68%
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
239.713%
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
447.619%
|
XOMA Corporation
|
-4.04 USD
|
172.277%
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
308.571%
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
233.333%
|
aTyr Pharma, Inc.
|
-0.94 USD
|
410.638%
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
182.955%
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
201.038%
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
154.991%
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
324.615%
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
214.961%
|
Akari Therapeutics, Plc
|
-2.04 USD
|
243.137%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
730100.0%
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
-37.089%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
389.109%
|
UroGen Pharma Ltd.
|
-3.55 USD
|
182.254%
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
264.045%
|
ZIVO Bioscience, Inc.
|
-4.60 USD
|
163.478%
|
Orgenesis Inc.
|
-1.91 USD
|
252.88%
|
Entera Bio Ltd.
|
-0.31 USD
|
1041.935%
|
GH Research PLC
|
-0.68 USD
|
529.412%
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
213.178%
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
111.574%
|
Xencor, Inc.
|
-2.08 USD
|
240.385%
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
407.368%
|
Replimune Group, Inc.
|
-3.24 USD
|
190.123%
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
451.807%
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
-6581.922%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
389.109%
|
Portage Biotech Inc.
|
-3.70 USD
|
178.919%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
542.424%
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
236.449%
|
OncoCyte Corporation
|
-3.75 USD
|
177.867%
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
218.699%
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
134.434%
|
Purple Biotech Ltd.
|
-0.09 USD
|
3351.67%
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
570.968%
|
scPharmaceuticals Inc.
|
-1.42 USD
|
305.634%
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
305.634%
|
HilleVax, Inc.
|
-3.04 USD
|
196.053%
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
451.807%
|
Tharimmune, Inc.
|
-107.08 USD
|
102.727%
|
Genprex, Inc.
|
-22.58 USD
|
112.932%
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
295.973%
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
1316.667%
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
88584.848%
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
1142.857%
|
OKYO Pharma Limited
|
-0.00 USD
|
486766.667%
|
Savara Inc.
|
-0.33 USD
|
984.848%
|
Curis, Inc.
|
-8.96 USD
|
132.589%
|
Daré Bioscience, Inc.
|
-4.15 USD
|
170.361%
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
300.0%
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
139.406%
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
294.667%
|
BeiGene, Ltd.
|
-8.45 USD
|
134.556%
|
Kiromic BioPharma, Inc.
|
-21.41 USD
|
113.638%
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
175.648%
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
310.072%
|
Erasca, Inc.
|
-0.83 USD
|
451.807%
|
bluebird bio, Inc.
|
-1.93 USD
|
251.295%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
353.913%
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
-228.09%
|
DBV Technologies S.A.
|
-0.76 USD
|
484.211%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
353.913%
|
Moderna, Inc.
|
-12.34 USD
|
123.663%
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
254.497%
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
404.167%
|
Molecular Templates, Inc.
|
-1.80 USD
|
262.222%
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
206.569%
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
294.667%
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
211.027%
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
335.484%
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
200.0%
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
220.661%
|
MacroGenics, Inc.
|
-0.15 USD
|
2046.667%
|
RenovoRx, Inc.
|
-0.99 USD
|
394.949%
|
Adicet Bio, Inc.
|
-3.31 USD
|
188.218%
|
Prime Medicine, Inc.
|
-2.18 USD
|
233.945%
|
Aditxt, Inc.
|
-4326.64 USD
|
100.067%
|
Adagene Inc.
|
-0.44 USD
|
763.636%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
1490.476%
|
Quantum-Si incorporated
|
-0.68 USD
|
529.412%
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
424.444%
|
Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
353.913%
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
5.195%
|
SciSparc Ltd.
|
-14.43 USD
|
120.236%
|
Vericel Corporation
|
-0.07 USD
|
4464.723%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
650.943%
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
163.341%
|
Generation Bio Co.
|
-1.96 USD
|
248.98%
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
220.661%
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
255.319%
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
177.249%
|
Invivyd, Inc.
|
-1.81 USD
|
261.326%
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
204.659%
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
130.29%
|
Spero Therapeutics, Inc.
|
0.43 USD
|
-579.07%
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
183.668%
|
2seventy bio, Inc.
|
-4.42 USD
|
166.063%
|
ADMA Biologics, Inc.
|
-0.13 USD
|
2346.154%
|
Clene Inc.
|
-9.43 USD
|
130.965%
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
451.807%
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
231.532%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
128.571%
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
284.81%
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
1427.273%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
-114.706%
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
189.024%
|
Finch Therapeutics Group, Inc.
|
-46.59 USD
|
106.267%
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
178.075%
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
163.617%
|
Evaxion Biotech A/S
|
-8.11 USD
|
136.005%
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
367.89%
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
193.59%
|
Trevena, Inc.
|
-54.51 USD
|
105.357%
|
Surrozen, Inc.
|
-21.33 USD
|
113.69%
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
280.247%
|
Cingulate Inc.
|
-311.99 USD
|
100.936%
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
109.717%
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
208.148%
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
109.392%
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
329.921%
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
889.189%
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
370.37%
|
Clearmind Medicine Inc.
|
-59.18 USD
|
104.934%
|
Kronos Bio, Inc.
|
-1.95 USD
|
249.744%
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
259.563%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
848.718%
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
420.879%
|
Statera Biopharma, Inc.
|
-4.97 USD
|
158.753%
|
ImmunityBio, Inc.
|
-1.15 USD
|
353.913%
|
Korro Bio, Inc.
|
-53.08 USD
|
105.501%
|
Kineta, Inc.
|
-1.28 USD
|
328.125%
|
BioVie Inc.
|
-7.30 USD
|
140.0%
|
Codexis, Inc.
|
-1.12 USD
|
360.714%
|
Celularity Inc.
|
-11.02 USD
|
126.497%
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
179.133%
|
Celcuity Inc.
|
-2.69 USD
|
208.55%
|
Virax Biolabs Group Limited
|
-3.36 USD
|
186.905%
|
Cibus, Inc.
|
-25.95 USD
|
111.252%
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
182600.0%
|
eFFECTOR Therapeutics, Inc.
|
-16.37 USD
|
117.838%
|
IN8bio, Inc.
|
-1.00 USD
|
392.0%
|
Kodiak Sciences Inc.
|
-4.97 USD
|
158.753%
|
Annexon, Inc.
|
-1.77 USD
|
264.972%
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
125.129%
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
121.824%
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
102.571%
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
214.063%
|
Eyenovia, Inc.
|
-0.66 USD
|
542.424%
|
Puma Biotechnology, Inc.
|
0.46 USD
|
-534.783%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
3330.088%
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
205.036%
|
Arcellx, Inc.
|
-1.47 USD
|
298.639%
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
413.978%
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
145.768%
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
284.81%
|
Moolec Science SA
|
-1.50 USD
|
294.667%
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
370.37%
|
Geron Corporation
|
-0.32 USD
|
1012.5%
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
285.987%
|
Royalty Pharma plc
|
3.41 USD
|
14.37%
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
279.141%
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
523.188%
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
124.641%
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
297.297%
|
Humacyte, Inc.
|
-1.07 USD
|
372.897%
|
Structure Therapeutics Inc.
|
-2.44 USD
|
219.672%
|
89bio, Inc.
|
-2.00 USD
|
246.0%
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
302.778%
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
103.967%
|
Genelux Corporation
|
-1.16 USD
|
351.724%
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
1106.897%
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
465.0%
|
Notable Labs, Ltd.
|
-5.03 USD
|
158.052%
|
Liquidia Corporation
|
-1.21 USD
|
341.322%
|
Mustang Bio, Inc.
|
-6.00 USD
|
148.667%
|
Immunovant, Inc.
|
-1.88 USD
|
255.319%
|
Quantum-Si incorporated
|
-0.68 USD
|
529.412%
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
763.636%
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
586.667%
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
229.778%
|
Acasti Pharma Inc.
|
-1.35 USD
|
316.296%
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
549.231%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
123.083%
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
206.96%
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
830.0%
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
218.699%
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
252.88%
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
223.729%
|
PepGen Inc.
|
-3.30 USD
|
188.485%
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
119.376%
|
United Therapeutics Corporation
|
21.04 USD
|
86.122%
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
304.196%
|
Solid Biosciences Inc.
|
-4.83 USD
|
160.455%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
1106.897%
|
Immuneering Corporation
|
-1.88 USD
|
255.319%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
209.774%
|
Silo Pharma, Inc.
|
-1.20 USD
|
343.333%
|
Belite Bio, Inc
|
-1.19 USD
|
345.378%
|
XOMA Corporation
|
-4.04 USD
|
172.277%
|
ARS Pharmaceuticals, Inc.
|
-0.57 USD
|
612.281%
|
Bionomics Limited
|
-1.02 USD
|
386.275%
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
85982.353%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
795.238%
|
uniQure N.V.
|
-6.47 USD
|
145.131%
|
Cassava Sciences, Inc.
|
-2.32 USD
|
225.862%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
1490.476%
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
313.139%
|
Forte Biosciences, Inc.
|
-24.92 USD
|
111.717%
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
1012.5%
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
287.179%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
3330.088%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
109.64%
|
FibroBiologics, Inc. Common Stock
|
-0.59 USD
|
594.915%
|
Altimmune, Inc.
|
-1.66 USD
|
275.904%
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
672.549%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
795.238%
|
Compugen Ltd.
|
-0.21 USD
|
1490.476%
|
Peak Bio, Inc.
|
- USD
|
-Infinity%
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
324.615%
|
Benitec Biopharma Inc.
|
-5.36 USD
|
154.478%
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
105.945%
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
154.275%
|
Zura Bio Limited
|
-2.09 USD
|
239.713%
|
PolyPid Ltd.
|
-16.99 USD
|
117.187%
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
185.38%
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
154.275%
|
Instil Bio, Inc.
|
-24.00 USD
|
112.167%
|
argenx SE
|
-5.16 USD
|
156.589%
|
Immunome, Inc.
|
-5.38 USD
|
154.275%
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
984.848%
|
Verona Pharma plc
|
-0.54 USD
|
640.741%
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
164.745%
|
Shattuck Labs, Inc.
|
-2.05 USD
|
242.439%
|
CervoMed Inc.
|
-0.82 USD
|
456.098%
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
119.085%
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
168.868%
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
134.556%
|
Moolec Science SA
|
-1.50 USD
|
294.667%
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
136.094%
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
147.947%
|
AnaptysBio, Inc.
|
-6.08 USD
|
148.026%
|
Design Therapeutics, Inc.
|
-1.19 USD
|
345.378%
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
173.367%
|
NeurAxis, Inc.
|
-4.03 USD
|
172.457%
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
137.775%
|
Lumos Pharma, Inc.
|
-4.18 USD
|
169.856%
|
Achilles Therapeutics plc
|
-1.74 USD
|
267.816%
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
164.745%
|
180 Life Sciences Corp.
|
-52.60 USD
|
105.551%
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
-329.412%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
848.718%
|
Nutriband Inc.
|
-0.69 USD
|
523.188%
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
248.98%
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
118.658%
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
247.475%
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
319.549%
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
500.0%
|
Palisade Bio, Inc.
|
-27.01 USD
|
110.811%
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
132.92%
|
Beam Therapeutics Inc.
|
-1.72 USD
|
269.767%
|
Neurogene Inc.
|
-2.83 USD
|
203.18%
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
173.0%
|
AEON Biopharma, Inc.
|
- USD
|
-Infinity%
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
222.689%
|
Sesen Bio, Inc.
|
-1.99 USD
|
246.734%
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
245.274%
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
112.041%
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
254.497%
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
404.167%
|
Athira Pharma, Inc.
|
-3.10 USD
|
194.194%
|
Vaccinex, Inc.
|
-43.68 USD
|
106.685%
|
HCW Biologics Inc.
|
-0.70 USD
|
517.143%
|
XOMA Corporation
|
-4.04 USD
|
172.277%
|
Nektar Therapeutics
|
-1.45 USD
|
301.379%
|
Arvinas, Inc.
|
-6.62 USD
|
144.109%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
730100.0%
|
Merus N.V.
|
-3.00 USD
|
197.333%
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
262.222%
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
447.619%
|
Rezolute, Inc.
|
-1.33 USD
|
319.549%
|
Clene Inc.
|
-9.43 USD
|
130.965%
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
258.696%
|
BeyondSpring Inc.
|
-0.54 USD
|
640.741%
|
Synlogic, Inc.
|
-8.81 USD
|
133.144%
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
28449.515%
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
106.23%
|
Peak Bio, Inc.
|
- USD
|
-Infinity%
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
378.095%
|
Krystal Biotech, Inc.
|
0.40 USD
|
-630.0%
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
333.6%
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
156.699%
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
479.221%
|
MannKind Corporation
|
-0.04 USD
|
6632.438%
|
Ikena Oncology, Inc.
|
-1.63 USD
|
279.141%
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
132.481%
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
307.092%
|
Gossamer Bio, Inc.
|
-1.18 USD
|
347.458%
|
CohBar, Inc.
|
-4.13 USD
|
170.702%
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
439.535%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
173.367%
|
Legend Biotech Corporation
|
-2.94 USD
|
199.32%
|
Mural Oncology plc
|
-12.43 USD
|
123.492%
|
Biora Therapeutics, Inc.
|
-7.87 USD
|
137.103%
|
PaxMedica, Inc. Common Stock
|
-11.00 USD
|
126.545%
|
Disc Medicine, Inc.
|
-3.43 USD
|
185.131%
|
Champions Oncology, Inc.
|
-0.54 USD
|
640.741%
|
REGENXBIO Inc.
|
-6.02 USD
|
148.505%
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
162.26%
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
586.667%
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
193.891%
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
285.987%
|
Vaxart, Inc.
|
-0.57 USD
|
612.281%
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
262.222%
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
556.25%
|
Cellectis S.A.
|
-1.77 USD
|
264.972%
|
Longeveron Inc.
|
-10.22 USD
|
128.571%
|
Repare Therapeutics Inc.
|
-2.23 USD
|
230.942%
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
150.345%
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
313.139%
|
Revolution Medicines, Inc.
|
-3.86 USD
|
175.648%
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
4072.789%
|
Third Harmonic Bio, Inc.
|
-0.78 USD
|
474.359%
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
234.562%
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
206.569%
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
1012.5%
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
79.217%
|
Denali Therapeutics Inc.
|
-1.06 USD
|
375.472%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
650.943%
|
Veru Inc.
|
-1.10 USD
|
365.455%
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
621.429%
|
Cingulate Inc.
|
-311.99 USD
|
100.936%
|
Passage Bio, Inc.
|
-1.86 USD
|
256.989%
|
Context Therapeutics Inc.
|
-1.50 USD
|
294.667%
|
Exicure, Inc.
|
-2.11 USD
|
238.389%
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
223.207%
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
401.031%
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
117.569%
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
191.25%
|
Nuvalent, Inc.
|
-2.17 USD
|
234.562%
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
220.165%
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
212.741%
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
328.125%
|
OmniAb, Inc.
|
-0.51 USD
|
672.549%
|
Anew Medical, Inc.
|
0.14 USD
|
-1985.714%
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
586.667%
|
Lipocine Inc.
|
-3.14 USD
|
192.994%
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
217.269%
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
672.549%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
138.22%
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
413.978%
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
240.385%
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
132.265%
|
Ocugen, Inc.
|
-0.26 USD
|
1223.077%
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
219.672%
|
Q32 Bio Inc.
|
-35.16 USD
|
108.305%
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
830.0%
|
Alumis Inc. Common Stock
|
-2.99 USD
|
197.659%
|
Equillium, Inc.
|
-0.38 USD
|
868.421%
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
2920100.0%
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
469.62%
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
101.162%
|
Galera Therapeutics, Inc.
|
-1.33 USD
|
319.549%
|
Evelo Biosciences, Inc.
|
-26.28 USD
|
111.111%
|
Comera Life Sciences Holdings, Inc.
|
-1.76 USD
|
265.909%
|
Dominari Holdings Inc.
|
-4.38 USD
|
166.667%
|
Edesa Biotech, Inc.
|
-2.93 USD
|
199.659%
|
vTv Therapeutics Inc.
|
-9.71 USD
|
130.072%
|
Bio-Techne Corporation
|
1.07 USD
|
-172.897%
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
146.13%
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
-34.562%
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
244.554%
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
322.901%
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
192.698%
|
Nkarta, Inc.
|
-2.40 USD
|
221.667%
|
BioCardia, Inc.
|
-8.19 USD
|
135.653%
|
Iterum Therapeutics plc
|
-2.96 USD
|
198.649%
|